NASDAQ, CRIS - Curis Inc
We are a drug discovery and development company that is committed to leveraging
our innovative signaling pathway drug technologies in seeking to create new
medicines, primarily for cancer. In expanding our drug development efforts in
the field of cancer through our targeted cancer drug development platform, we
are building upon our past experiences in targeting signaling pathways in the
areas of cancer, neurological disease and cardiovascular disease.
Signaling pathways are the means by which cells exchange instructional messages
that regulate specific biological functions. Healthy, normal cells require a
balanced network of signaling pathways that govern daily cell function,
including proliferation, metabolism, and ordinary cell death. Genetic,
environmental and other factors can cause activation or repression of these
signaling pathways, which can possibly lead to complex diseases such as cancer. ...
Read SEC Filing on NASDAQ.com »